StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s): SZLSF

Healthcare Biotechnology

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.

TSX:SZLS - Post by User

StageZero Life Sciences Ltd

Bullboard Posts

Comment by Liked2Thinkon Sep 14, 2020 3:16pm

139 Views

Post# 31554040

RE:RE:RE:RE:RE:Analyst suggest potential $1B market cap

this seems to be the going concenses.

i hope for great news all the time

Will be great if Tripp is planning for it but I still think its too soon. So many new hires lately, Aristotle not quite ready for commercial. Would be nice if our new partners have been using colonsentry and what not lately but I think they would rather just wait for aristotle.

hope im wrong but I was thinking it would be early in the new year we start getting info like that.

Bullboard Posts

One of the best Venture pharma stocks has grown even stronger